Chitotriosidase activity in the serum of patients with sarcoidosis and pulmonary tuberculosis

Respiration

Volumn 74, Issue 5, 2007, Pages 548-552

  Bargagli, Elena ^a,b   Margollicci, Maria ^a   Nikiforakis, Nikolaos ^a   Luddi, Alice ^a   Perrone, Anna ^a   Grosso, Salvatore ^a   Rottoli, Paola ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Bronchoalveolar lavage; Chitotriosidase; Pulmonary tuberculosis; Sarcoidosis

Indexed keywords

CHITOTRIOSIDASE;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SARCOIDOSIS;

ADULT; AGED; FEMALE; HEXOSAMINIDASES; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; SARCOIDOSIS, PULMONARY; TUBERCULOSIS, PULMONARY;

EID: 34547615729     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000100555     Document Type: Article

References (43)

1. Wajner A, Michelin K, Burin MG, et al: Biochemical characterization of chitotriosidase enzyme: comparison between normal individuals and patients with Gaucher and with Niemann-Pick diseases. Clin Biochem 2004;37:893-897.
2. Aguilera B, Ghauharali-van der Vlugt K, Helmond MTJ, et al: Transglycosidase activity of chitotriosidase. J Biol Chem 2003;42:40911-40916.
3. Malaguarnera L, Musumeci M, Di Rosa M, et al: Interferon-gamma, tumor necrosis factor-alpha, and lipopolysaccharide promote chitotriosidase gene expression in human macrophages. J Clin Lab Anal 2005;19:128-132.
4. Korolenko TA, Zhanaeva SY, Falameeva OV, et al: Chitotriosidase as a marker of macrophage stimulation. Bull Exp Biol Med 2000;130:948-950.
5. Michelakakis H, Dimitriou E, Labadaridis I: The expanding spectrum of disorders with elevated plasma chitotriosidase activity: an update. J Inherit Metab Dis 2004;27:705-706.
6. Altarescu G, Rudensky B, Abrahamov A, et al: Plasma chitotriosidase activity in patients with beta-thalassemia. Am J Hematol 2003;72:285-286.
7. Barone R, Simpore J, Malaguarnera L, et al: Plasma chitotriosidase activity in acute Plasmodium falciparum malaria. Clin Chim Acta 2003;331:79-85.
8. Renkema GH, Boot RG, Au FL, et al: Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages. Eur J Biochem 1988;251:504-509.
9. Sotgiu S, Barone R, Zanda B, et al: Chitotriosidase in patients with acute ischemic stroke. Eur Neurol 2005;54:149-153.
10. Chien YH, Chen JH, Hwu WL: Plasma chitotriosidase activity and malaria. Clin Chim Acta 2005;353:215.
11. Labadaridis I, Dimitriou E, Theodorakis M, et al: Chitotriosidase in neonates with fungal and bacterial infections. Arch Dis Child Fetal Neonatal Ed 2005;90:531-532.
12. Grosso S, Margollicci MA, Bargagli E, et al: Serum levels of chitotriosidase as a marker of disease activity and clinical stage in sarcoidosis. Scand J Clin Lab Invest 2004;64:57-62.
13. Bargagli E, Margollicci MA, Perrone A, et al: Chitotriosidase analysis in BAL of patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis, in press.
14. Baughman RP, Lower EE, Du Bois RM: Sarcoidosis. Lancet 2003;361:1111-1118.
15. Sharma P, Smith I, Maguire G, et al: Clinical value of ACE genotyping in diagnosis of sarcoidosis. Lancet 1997;349:1602-1603.
16. Rottoli P, Bargagli E: Is bronchoalveolar lavage obsolete in the diagnosis of interstitial lung disease? Curr Opin Pulm Med 2003;9:418-425.
17. Calhoun WJ, Salisbury SM, Chosy LW, et al: Increased alveolar macrophage chemiluminescence and airspace cell superoxide production in active pulmonary sarcoidosis. J Lab Clin Med 1998;112:147-156.
18. Dai H, Guzman J, Chen B, et al: Production of soluble TNF receptor and TNF alpha by alveolar macrophages in sarcoidosis and extrinsic allergic alveolitis. Chest 2005;127:251-256.
19. Ziegenhagen MW, Rothe ME, Zissel G, et al: Exaggerated TNF alpha release of alveolar macrophages in corticosteroid resistant sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2002;19:185-190.
20. Aladesanmi OA: Sarcoidosis: an update for primary care physicians. Med Gen Med 2004;6:7.
21. Salfinger M, Hale YM, Driscoll JR: Diagnostic tools in tuberculosis. Present and future. Respiration 1998;65:163-170.
22. Lee C, Kim WJ, Yoo C, et al: Response to empirical anti-tuberculosis treatment in patients with sputum smear-negative presumptive pulmonary tuberculosis. Respiration 2005;72:369-374.
23. Rivas-Santiago B, Vieyra-Reyes P, Araujo Z: Cell immunity response in human pulmonary tuberculosis. Invest Clin 2005;46:391-412.
24. Rajavelu P, Das SD: Th2-type immune response observed in healthy individuals to sonicate antigen prepared from the most prevalent Mycobacterium tuberculosis strain with single copy of IS6110. FEMS Immunol Med Microbiol 2005;45:95-102.
25. Belli F, Capra A, Moraiti A, et al: Cytokines assay in peripheral blood and bronchoalveolar lavage in the diagnosis and staging of pulmonary granulomatous diseases. Int J Immunopathol Pharmacol 2000;13:61-67.
26. Mrazek F, Sekerova V, Drabek J, et al: Expression of the chemokine PARC mRNA in bronchoalveolar lavage cells of patients with sarcoidosis. Immunol Lett 2002;84:17-22.
27. Ziegenhagen MW, Rothe ME, Schlaak M, et al: bronchoalveolar and serological parameters reflecting the severity of sarcoidosis. Eur Respir J 2003;21:407-413.
28. Kantrow SP, Meyer KC, Kidd P, et al: The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis. Eur Respir J 1997;10:2716-2721.
29. Rothkrantz-Kos S, Drent M, Schmitz MP, et al: Reference values of soluble interleukin-2 receptor on the IMMULITE. Clin Chem Lab Med 2004;42: 976-977.
30. Straub JP, van Kamp GJ, van Maarsseveen TC, et al: Biochemical parameters in BAL of sarcoidosis. Sarcoidosis 1995;12:51-57.
31. Sharma OP: Pulmonary sarcoidosis: management. Postgrad Med 2002;48:135-141.
32. Papakosta D, Kyriazis G, Gioulekas D, et al: Variations in alveolar cell populations, lymphocyte subsets and NK cells in different stages of active pulmonary sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2005;22:21-26.
33. Drent M, Jacobs JA, de Vries J, et al: Does the cellular bronchoalveolar lavage fluid profile reflect the severity of sarcoidosis? Eur Respir J 1999;13:1338-1344.
34. Rothkrantz-Kos S, van Dieijen-Visser MP, Mulder PGH, et al: Potential usefulness of inflammatory markers to monitor respiratory functional impairment in sarcoidosis. Clin Chem 2003;49:1510-1517.
35. Hunninghake GW, Costabel U, Ando M, et al: ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999;16:149-173.
36. Baudin B: Angiotensin I-converting enzyme (ACE) for sarcoidosis diagnosis (in French). Pathol Biol (Paris) 2005;53:183-188.
37. Schurmann M: Angiotensin-converting enzyme gene polymorphisms in patients with pulmonary sarcoidosis: impact on disease severity. Am J Pharmacogenomics 2003;3:233-243.
38. Malaguarnera L, Rosa MD, Zambito AM, et al: Potential role of chitotriosidase gene in nonalcoholic fatty liver disease evolution. Am J Gastroenterol 2006;101:2060-2069.
39. Malaguarnera L, Di Rosa M, Zambito AM, et al: Chitotriosidase gene expression in Kupffer cells from patients with non-alcoholic fatty liver disease. Gut 2006;55:1313-1320.
40. Elias JA, Homer RJ, Hamid Q, et al: Chitinases and chitinase-like proteins in T H 2 inflammation and asthma. J Allergy Clin Immunol 2005;116:497-500.
41. Prasse A, Pechkovsky DV, Toews GB, et al: A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am J Respir Crit Care Med 2006;173:781-792.
42. Gaga M, Papamicholis G, Bakakos P, et al: Tuberculous effusion: ADA activity correlates with CD4+ cells members in the fluid and the pleura. Respiration 2005;72:160-165.
43. Lin FC, Chen Ye, Chen FJ, et al: Cytokines and fibrinolytic enzymes in tuberculous and parapneumonic effusions. Clin Immunol 2005;116:166-173.